Nearly three decades after the initial discovery of rye pollen’s potential in slowing tumor growth, scientists at Northwestern University have unveiled the three-dimensional structures of two key molecules, secalosides A and B. This breakthrough, published in the January 14 issue of the Journal of the American Chemical Society, could pave the way for innovative cancer treatments.
The study, led by Northwestern’s Karl A. Scheidt, marks a significant milestone in cancer research. “In preliminary studies, other researchers found that rye pollen could help different animal models clear tumors through some unknown, non-toxic mechanism,” Scheidt explained. “Now that we confirmed the structure of these molecules, we can find the active ingredient—or what part of the molecule is doing the work. This is an exciting starting point to make better versions of these molecules that could possibly inform approaches to cancer therapy.”
Nature as Inspiration for Medicine
Throughout history, nature has been a rich source of inspiration for medical treatments. Many of today’s most effective drugs originated from natural sources rather than laboratories. For instance, morphine, a critical pain reliever, is derived from the opium poppy, while Taxol, a widely used cancer treatment, was originally isolated from the Pacific yew tree. Statins, which help lower cholesterol, trace their origins to fungi.
“Natural products aren’t necessarily effective drugs on their own, but they are great leads,” Scheidt noted. “We can find inspiration in natural products and use chemistry to make better versions that are orally available, survive the metabolism, and hit the right targets.”
Rye pollen, a staple cereal crop, could potentially join these ranks. Although many consumers already use rye pollen extract in supplement form for prostate health, its pharmaceutical potential remains untapped. Understanding its mechanism required unraveling the molecules’ precise three-dimensional shapes, a challenge that had stymied scientists for years.
A Molecular Mystery
Traditional techniques, such as advanced nuclear magnetic resonance spectroscopy, failed to fully reveal the orientation of the molecules’ key parts, leading to two competing structural models. These models had the same atoms, connections, and overall shape, but differed in a crucial way: the central part of the molecules were mirror images of each other, a subtle distinction that could determine biological activity.
“It’s like your hands,” Scheidt said. “They are mirror images of each other, but you need a different glove for each. If you had two left-handed gloves, it wouldn’t work because your hands can’t be superimposed on top of one another.”
Building from Scratch
To resolve this long-standing mystery, the Northwestern team employed total synthesis, a method of constructing natural molecules in the laboratory. This approach was challenging due to the molecules’ complex structure, particularly the tightly compressed, 10-membered ring at their cores.
Scheidt and his team devised an innovative solution by first constructing a larger, more flexible ring, then triggering a reaction to snap it into the desired shape. After synthesizing both structural versions of the secalosides, they compared them to samples isolated from rye pollen, ultimately identifying the correct structure.
“We’ve demonstrated we can make the core of this natural product,” Scheidt stated. “Now, we’re trying to find potential collaborators in immunology who could help us translate this to a possible clinical endpoint.”
The study, “Synthesis and structural confirmation of secalosides A and B,” was supported by the National Institute of General Medical Science, the Chemistry of Life Processes Institute Lambert Fellowship, and the National Science Foundation.
Implications and Future Prospects
This discovery opens new avenues for cancer research, potentially leading to the development of novel, non-toxic cancer therapies. By understanding the structure of these molecules, scientists can explore their interactions with the immune system, possibly inspiring new strategies for cancer treatment.
The announcement comes as the scientific community increasingly turns to nature for medical breakthroughs. With the correct molecular blueprint now available, the potential for rye pollen to contribute to cancer therapy is immense. As researchers seek collaborations to advance this work, the future of cancer treatment may soon include innovations inspired by this humble cereal crop.
